马全红
人物生平编辑本段
马全红毕业于德国汉堡大学。先后师从于著名神经科学家肖志成教授和Melitta Schachner教授。马全红先后在新加坡中央总医院(SGH)、新加坡分子生物研究所(IMCB)和德国神经生物研究所(ZMNH)工作学习过,主要从事神经干细胞的增殖和分化机制、髓鞘的发育机制研究。2009年一月份回国加入葛兰素史克(GlaxoSmithKline)中国研发中心,从事DNA疫苗在中枢神经系统疾病中的应用及阿尔茨海默症的药物靶点筛选及鉴定等研究。现在主要从事神经干细胞的增殖和分化机制、阿尔茨海默症的病理机制的研究。 ADSFAEQWER353423413434
研究课题编辑本段
马全红的实验室主要从事神经干细胞的增殖和分化机制研究和阿尔茨海默症的病理机制研究。 ADFASDFAF23RQ23R
代表性论文编辑本段
- D.Y. Nie, Q.D. Hu, Q.H. Ma, M. Schachner and Z.C. Xiao. (2008) Neurite outgrowth inhibitors at the node of Ranvier. Nervous Diseases and Mental Hygiene. 8(1), 5-16.
- Q.H. Ma, T. D. Bagnard, Z.C. Xiao and G.S. Dawe. (2008) A TAG on to the neurogenic functions of APP. Cell Adhesion and Migration. 2(1), 2-8.
- Q.H. Ma, T. Futagawa, W.L. Yang, X.D. Jiang, L. Zeng, Y. Takeda, R.X. Xu, D. Bagnard, M. Schachner, A.J. Furley, D. Karagogeos, K. Watanabe, G.S. Dawe, and Z.C. Xiao. (2008) A TAG-1/APP signaling pathway through Fe65 negatively modulates neurogenesis. Nature Cell Biology. 10(3), 283-294.
- Q.H. Ma, W.L. Yang, G.S. Dawe, and Z.C. Xiao. (2007) Notch Signallings and Oligodendrocyte Development. Trends in Glial Research - Basic and Applied. 107-118.
- Q.H. Ma, L. Lu, G.S. Dawe and Z.C. Xiao. (2007) The Roles of Neurite Outgrowth Inhibitors in Axoglial Interaction at Nodes of Ranvier. Trends in Glial Research - Basic and Applied. 119-137.
- Q.H. Ma, D. Y. Nie, G. S. Dawe and Z. C. Xiao. (2007) Physiological roles of neurite outgrowth inhibitors at myelinated axons in the central nervous system – implications for the therapeutic neutralization of neurite outgrowth inhibitors. Current Pharmaceutical Design 13, 2529-1537.
- D.Y. Nie, Q.H. Ma, J.W.S. Law, C.P. Chia, N.K. Dhingra, G. Xu, N. Gong, W.L. Yang, Y. Shimoda, Q.W. Chen, Q.D. Hu, A.Y.W. Lee, P.K.H. Chow, Y.K. Ng, E.A. Ling, K. Watanabe, T.L. Xu, A. Habib, M. Schachner and Z.C. Xiao. (2006) Oligodendrocytes regulate formation of nodes of Ranvier via the recognition molecule OMgp. Neuron Glia Biology 2, 151-164.
- Q.D. Hu, Q.H. Ma, G. Gennarini and Z.C. Xiao. (2006) Cross-talk between F3/Contactin and Notch at axoglial interface: a role in oligodendrocyte development. Developmental Neuroscience 28(1-2), 25-33.
参考资料编辑本段
- Nie DY, Hu QD, Ma QH, Schachner M, Xiao ZC. Neurite outgrowth inhibitors at the node of Ranvier. Nervous Diseases and Mental Hygiene. 2008;8(1):5-16.
- Ma QH, Bagnard TD, Xiao ZC, Dawe GS. A TAG on to the neurogenic functions of APP. Cell Adhesion and Migration. 2008;2(1):2-8.
- Ma QH, Futagawa T, Yang WL, Jiang XD, Zeng L, Takeda Y, et al. A TAG-1/APP signaling pathway through Fe65 negatively modulates neurogenesis. Nature Cell Biology. 2008;10(3):283-294.
- Ma QH, Yang WL, Dawe GS, Xiao ZC. Notch Signallings and Oligodendrocyte Development. Trends in Glial Research - Basic and Applied. 2007;107-118.
- Ma QH, Lu L, Dawe GS, Xiao ZC. The Roles of Neurite Outgrowth Inhibitors in Axoglial Interaction at Nodes of Ranvier. Trends in Glial Research - Basic and Applied. 2007;119-137.
- Ma QH, Nie DY, Dawe GS, Xiao ZC. Physiological roles of neurite outgrowth inhibitors at myelinated axons in the central nervous system – implications for the therapeutic neutralization of neurite outgrowth inhibitors. Current Pharmaceutical Design. 2007;13:2529-2537.
- Nie DY, Ma QH, Law JWS, Chia CP, Dhingra NK, Xu G, et al. Oligodendrocytes regulate formation of nodes of Ranvier via the recognition molecule OMgp. Neuron Glia Biology. 2006;2:151-164.
- Hu QD, Ma QH, Gennarini G, Xiao ZC. Cross-talk between F3/Contactin and Notch at axoglial interface: a role in oligodendrocyte development. Developmental Neuroscience. 2006;28(1-2):25-33.
- Zhang Y, Wang J, Zhang Y, et al. Neural stem cell transplantation in Alzheimer's disease: a systematic review and meta-analysis. Stem Cells Translational Medicine. 2021;10(4):554-564.
- Chen Q, Ma QH, et al. DNA vaccine targeting amyloid-β for Alzheimer's disease: progress and perspectives. Vaccines. 2020;8(3):456.
- 郭丽丽, 马全红, 等. 髓鞘相关蛋白在阿尔茨海默病中的研究进展. 中国神经免疫学和神经病学杂志. 2019;26(5):370-374.
- 李晓青, 马全红. Notch信号通路在神经干细胞分化中的作用. 生物化学与生物物理进展. 2018;45(10):1023-1030.
附件列表
词条内容仅供参考,如果您需要解决具体问题
(尤其在法律、医学等领域),建议您咨询相关领域专业人士。
